DE60216457D1 - Carbamate verbindungen zur behandlung oder verhutung von psychotischen krankheiten - Google Patents

Carbamate verbindungen zur behandlung oder verhutung von psychotischen krankheiten

Info

Publication number: DE60216457D1
Authority: DE; Germany
Prior art keywords: preparation; treatment; carbamate compounds; psychotic diseases; psychotic
Prior art date: 2001-02-27
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE60216457T

Other languages

English (en)

Other versions

DE60216457T2 (de

Inventor

Carlos Plata-Salaman

Boyu Zhao

Roy Twyman

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Janssen Pharmaceuticals Inc

Original Assignee

Ortho McNeil Pharmaceutical Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-02-27

Filing date

2002-02-21

Publication date

2007-01-11

2002-02-21 Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc

2007-01-11 Publication of DE60216457D1 publication Critical patent/DE60216457D1/de

2007-09-20 Application granted granted Critical

2007-09-20 Publication of DE60216457T2 publication Critical patent/DE60216457T2/de

2022-02-22 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DE60216457T 2001-02-27 2002-02-21 Carbamate verbindungen zur behandlung oder verhutung von psychotischen krankheiten Expired - Lifetime DE60216457T2 (de)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US81761		1998-05-20
US27188901P	2001-02-27	2001-02-27
US271889P		2001-02-27
PCT/US2002/006119 WO2002067927A1 (en)	2001-02-27	2002-02-21	Carbamate compounds for use in preventing or treating psychotic disorders
US10/081,761 US6541513B2 (en)	2001-02-27	2002-02-21	Carbamate compounds for use in preventing or treating psychotic disorders

Publications (2)

Publication Number	Publication Date
DE60216457D1 true DE60216457D1 (de)	2007-01-11
DE60216457T2 DE60216457T2 (de)	2007-09-20

Family

ID=26765939

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE60216457T Expired - Lifetime DE60216457T2 (de)	2001-02-27	2002-02-21	Carbamate verbindungen zur behandlung oder verhutung von psychotischen krankheiten

Country Status (25)

Country	Link
US (1)	US6541513B2 (de)
EP (1)	EP1401424B1 (de)
JP (1)	JP4276841B2 (de)
KR (1)	KR100886578B1 (de)
CN (1)	CN1262271C (de)
AR (1)	AR032876A1 (de)
AT (1)	ATE346597T1 (de)
AU (1)	AU2002242296B2 (de)
BR (1)	BR0207829A (de)
CA (1)	CA2439480C (de)
CZ (1)	CZ302412B6 (de)
DE (1)	DE60216457T2 (de)
DK (1)	DK1401424T3 (de)
ES (1)	ES2275844T3 (de)
HU (1)	HUP0303342A3 (de)
IL (2)	IL157588A0 (de)
MX (1)	MXPA03007722A (de)
NO (1)	NO20033801L (de)
NZ (1)	NZ527991A (de)
PL (1)	PL365021A1 (de)
PT (1)	PT1401424E (de)
RS (1)	RS51056B (de)
RU (1)	RU2302240C2 (de)
TW (1)	TWI251486B (de)
WO (1)	WO2002067927A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1250213C (zh) *	2000-07-21	2006-04-12	奥索-麦克尼尔药品公司	用于预防或治疗神经性疼痛和丛集性头痛及有或没有先兆的偏头痛的氨基甲酸酯化合物
ATE361745T1 (de) *	2001-02-27	2007-06-15	Ortho Mcneil Pharm Inc	Carbamatverbindungen zur vorbeugung oder behandlung von neurodegenerativen störungen
NZ546549A (en)	2001-02-27	2007-11-30	Ortho Mcneil Pharm Inc	Carbamate compounds for use in preventing or treating anxiety disorders
MXPA04000554A (es)	2001-07-16	2005-02-17	Johnson & Johnson	Compuestos de carbamato para utilizarse en la prevencion o tratamiento del dolor neuropatico y el dolor asociado con la cefalea acuminada y migranosa.
WO2005107719A2 (en) *	2004-05-06	2005-11-17	Sandoz Ag	Pharmaceutical composition comprising hydrophobic drug having improved solubility
JP5094720B2 (ja) *	2005-07-26	2012-12-12	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	サブスタンス関連障害を処置する方法
US20080317883A1 (en) *	2006-10-30	2008-12-25	Yong Moon Choi	Methods for treating depression
US20080103199A1 (en) *	2006-10-31	2008-05-01	Haas Magali	Treatment of pervasive developmental disorders
US8609849B1 (en)	2010-11-30	2013-12-17	Fox Chase Chemical Diversity Center, Inc.	Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
EP2970111A4 (de)	2013-03-12	2017-01-18	Bio-Pharm Solutions Co., Ltd.	Phenylcarbamatverbindung und zusammensetzung zur verhinderung oder behandlung einer nervengas-vermittelten krankheit damit
KR101717872B1 (ko)	2013-03-12	2017-03-17	(주)바이오팜솔루션즈	소아 간질 및 간질-관련 증후군의 예방 또는 치료용 페닐카바메이트 화합물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3313692A (en) *	1958-04-21	1967-04-11	Armour Pharma	Method of inducing calming and muscle relaxation with carbamates
US3265728A (en) *	1962-07-18	1966-08-09	Armour Pharma	Substituted phenethyl carbamates
US5492930A (en) *	1994-04-25	1996-02-20	Schering Corporation	Method and formulation for treating CNS disorders
US5698588A (en) *	1996-01-16	1997-12-16	Yukong Limited	Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol

2002
- 2002-02-21 IL IL15758802A patent/IL157588A0/xx unknown
- 2002-02-21 WO PCT/US2002/006119 patent/WO2002067927A1/en active IP Right Grant
- 2002-02-21 AT AT02707927T patent/ATE346597T1/de active
- 2002-02-21 NZ NZ527991A patent/NZ527991A/en unknown
- 2002-02-21 MX MXPA03007722A patent/MXPA03007722A/es active IP Right Grant
- 2002-02-21 US US10/081,761 patent/US6541513B2/en not_active Expired - Lifetime
- 2002-02-21 EP EP02707927A patent/EP1401424B1/de not_active Expired - Lifetime
- 2002-02-21 BR BR0207829-5A patent/BR0207829A/pt not_active Application Discontinuation
- 2002-02-21 RS YUP-675/03A patent/RS51056B/sr unknown
- 2002-02-21 DE DE60216457T patent/DE60216457T2/de not_active Expired - Lifetime
- 2002-02-21 HU HU0303342A patent/HUP0303342A3/hu unknown
- 2002-02-21 KR KR1020037011292A patent/KR100886578B1/ko active IP Right Grant
- 2002-02-21 RU RU2003128983/14A patent/RU2302240C2/ru active
- 2002-02-21 DK DK02707927T patent/DK1401424T3/da active
- 2002-02-21 ES ES02707927T patent/ES2275844T3/es not_active Expired - Lifetime
- 2002-02-21 AU AU2002242296A patent/AU2002242296B2/en not_active Ceased
- 2002-02-21 PL PL02365021A patent/PL365021A1/xx unknown
- 2002-02-21 PT PT02707927T patent/PT1401424E/pt unknown
- 2002-02-21 CZ CZ20032297A patent/CZ302412B6/cs not_active IP Right Cessation
- 2002-02-21 CA CA2439480A patent/CA2439480C/en not_active Expired - Fee Related
- 2002-02-21 CN CNB028089235A patent/CN1262271C/zh not_active Expired - Fee Related
- 2002-02-21 JP JP2002567294A patent/JP4276841B2/ja not_active Expired - Lifetime
- 2002-02-27 AR ARP020100702A patent/AR032876A1/es unknown
- 2002-03-05 TW TW091103972A patent/TWI251486B/zh not_active IP Right Cessation
2003
- 2003-08-26 NO NO20033801A patent/NO20033801L/no not_active Application Discontinuation
- 2003-08-26 IL IL157588A patent/IL157588A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
PT1401424E (pt)	2007-02-28
JP2004523556A (ja)	2004-08-05
HUP0303342A2 (hu)	2004-01-28
DK1401424T3 (da)	2007-02-26
US6541513B2 (en)	2003-04-01
EP1401424B1 (de)	2006-11-29
IL157588A (en)	2009-12-24
NO20033801D0 (no)	2003-08-26
HUP0303342A3 (en)	2012-07-30
RU2003128983A (ru)	2005-03-10
ES2275844T3 (es)	2007-06-16
NO20033801L (no)	2003-10-22
EP1401424A1 (de)	2004-03-31
CZ302412B6 (cs)	2011-05-04
AU2002242296B2 (en)	2006-06-29
CN1505507A (zh)	2004-06-16
MXPA03007722A (es)	2004-11-12
KR20030076713A (ko)	2003-09-26
CA2439480C (en)	2011-04-26
BR0207829A (pt)	2004-06-22
DE60216457T2 (de)	2007-09-20
KR100886578B1 (ko)	2009-03-05
WO2002067927A1 (en)	2002-09-06
PL365021A1 (en)	2004-12-27
JP4276841B2 (ja)	2009-06-10
TWI251486B (en)	2006-03-21
CZ20032297A3 (cs)	2004-06-16
CA2439480A1 (en)	2002-09-06
CN1262271C (zh)	2006-07-05
US20020165272A1 (en)	2002-11-07
RU2302240C2 (ru)	2007-07-10
AR032876A1 (es)	2003-11-26
RS51056B (sr)	2010-10-31
RS67503A (en)	2006-12-15
ATE346597T1 (de)	2006-12-15
NZ527991A (en)	2005-04-29
IL157588A0 (en)	2004-03-28

Publication	Publication Date	Title
ATE390407T1 (de)	2008-04-15	Phenethanolamin-derivate zur behandlung von atemwegserkrankungen
DE60230425D1 (de)	2009-01-29	Phenethanolamin-derivate zur behandlung von erkrankungen der atemwege
DE602004028763D1 (de)	2010-09-30	Te zur behandlung von virenerkrankungen
DE60124302D1 (de)	2006-12-14	Thiazolderivate zur behandlung von ppar-lierte krankheiten
DE60239648D1 (de)	2011-05-12	Pharmazeutische Zusammensetzungen zur Behandlung von Asthma
ATE551340T1 (de)	2012-04-15	Azabicyclisch- substituierte annelierte heteroaryl-verbinungen für die behandlung von krankheiten
EP1534074A4 (de)	2008-01-09	Kombinationstherapie zur behandlung von fettleibigkeit
ATE440866T1 (de)	2009-09-15	Nogo-a-neutralisierende immunglobuline zur behandlung neurologischer krankheiten
DE60208221D1 (de)	2006-01-26	Heterozyklische verbindungen zur behandlung von harnwegserkrankungen
DE50206657D1 (de)	2006-06-08	Pharmazeutische zusammensetzung zur behandlung von multiple sklerose
ATE417037T1 (de)	2008-12-15	Diarylharnstoffderivate, die sich zur behandlung von proteinkinaseabhängigen krankheiten eignen
DE602004029580D1 (de)	2010-11-25	Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen
DE60123238D1 (de)	2006-11-02	Zusammensetzungen zur behandlung von autoimmunkrankheiten
DE60208186D1 (de)	2006-01-26	Chinazolin- und chinazolinähnliche verbindungen zur behandlung von integrinvermittelten erkrankungen
DE60204466D1 (de)	2005-07-07	Integrinhemmer zur behandlung von augenkrankheiten
ATE443704T1 (de)	2009-10-15	Pyridopyrimidinone zur behandlung von krebserkrankungen
DE60027209D1 (de)	2006-05-18	Arzneimittel enthaltend hydroxyapatite zur behandlung von knochengewebserkrankungen
DE50013843D1 (de)	2007-01-18	Arzneimittel zur behandlung von darmerkrankungen
DE60236743D1 (de)	2010-07-29	Zur behandlung androgenabhängiger krankheiten
DE60238765D1 (de)	2011-02-10	Carbamatverbindungen zur behandlung von schmerz
DE602004022153D1 (de)	2009-09-03	Verbindungen zur behandlung von obesitas
DE60218375D1 (de)	2007-04-12	Pharmazeutische Zusammensetzung zur Behandlung gynäkologischer Erkrankungen
DE60216457D1 (de)	2007-01-11	Carbamate verbindungen zur behandlung oder verhutung von psychotischen krankheiten
EP1494696A4 (de)	2006-01-25	Behandlung von lungenerkrankungen
ATE312104T1 (de)	2005-12-15	Verbindungen zur behandlung von beeinträchtigten fundischen entspannung

Legal Events

Date	Code	Title	Description
2007-12-20	8364	No opposition during term of opposition